Furthermore, evidence for the impact of changes in pathology was derived by the observation that a 75-gene signature that effectively discriminated cancer cells also predicted disease outcomes in primary lung cancer patients, as well as in p53 mutations that influence prognosis. This evidence concerns the gene TP53 and cancer.